STOCK TITAN

Hypera Sa - HYPMY STOCK NEWS

Welcome to our dedicated page for Hypera Sa news (Ticker: HYPMY), a resource for investors and traders seeking the latest updates and insights on Hypera Sa stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Hypera Sa's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Hypera Sa's position in the market.

News
Rhea-AI Summary

Ontex Group NV reported its Q3 2021 results, achieving revenue of €512 million, stable on a like-for-like (LFL) basis compared to the prior year and a 2% sequential increase. Cost inflation and supply chain disruptions significantly impacted adjusted EBITDA, which fell to €40 million, down 29.9% year-on-year, leading to an adjusted EBITDA margin of 7.8%. Net debt slightly decreased to €837 million. Strategic priorities emphasize cost reduction, category focus, and sustainability efforts, with a revised FY 2021 outlook forecasting a LFL revenue decline of approximately 1% and an adjusted EBITDA margin around 9%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.89%
Tags
none
-
Rhea-AI Summary

Ontex Group NV has finalized a settlement with Hypera S.A. for 500 million Brazilian Reais (€81 million), following earlier agreement on September 15, 2021. This settlement resolves claims from the acquisition of Hypera's Brazilian personal hygiene business in March 2017, valued at 1 billion Brazilian Reais. After deducting arbitration costs of approximately €7 million, Ontex plans to utilize the remaining funds to reduce debt and leverage. The cash flow aligns with Ontex's strategy to enhance financial stability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.38%
Tags
-
Rhea-AI Summary

Ontex Group NV has settled claims with Hypera S.A. regarding the acquisition of Hypera's Brazilian personal hygiene business. Under the agreement, Ontex will receive 500 million Brazilian Reais (approximately €81 million) by October 1, 2021. This settlement concludes arbitration initiated by Ontex and aims to reduce debt, aligning with the company's strategy to decrease leverage.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags

FAQ

What is the current stock price of Hypera Sa (HYPMY)?

The current stock price of Hypera Sa (HYPMY) is $3.25 as of February 28, 2025.

What is the market cap of Hypera Sa (HYPMY)?

The market cap of Hypera Sa (HYPMY) is approximately 3.8B.
Hypera Sa

OTC:HYPMY

HYPMY Rankings

HYPMY Stock Data

3.81B
632.68M
0.01%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Brazil
São Paulo